Thymia is on a mission to make mental health as objectively measurable and monitorable as physical health. Thymia’s AI-powered mental health assessments identify mental illness and its underlying symptoms specifically, accurately and objectively.
Over 1 billion people are affected by poor mental health globally, but more than 75% of them will never receive the help they need. As waiting times soar, specialist clinician numbers are shrinking; on average it now takes over 10 years to find the right treatment for depression, with GPs correctly diagnosing it in fewer than 50% of cases.
Thymia’s AI-powered mental health assessments allow providers, payors and employers to effectively understand and treat mental health issues. They also provide in-depth insights into mental health conditions and symptoms to support clinicians in triaging, diagnosing and treating mental illness. Leveraging engaging games for assessments, Thymia’s tools offer a frictionless experience, effortlessly pinpointing and tracking mental health biomarkers for all.
Dr Emilia Molimpakis
Emilia is a neuroscientist with a PhD & Postdoc from UCL in Linguistics, Neuroscience & Psychology. She is an expert in using language as a biomarker for cognition – there are fewer than 10 people in the world doing exactly what she does. Emilia won the Young Innovator’s Award 2020-21, has given a Ted Talk and was recently named one of the top scientists for mental health worldwide.
Dr Stefano Goria
Stefano has over 17 years of expertise in bringing cutting edge mathematical models to production: he has a PhD in Theoretical Physics and has worked as a quantitative analyst in large investment banks (JP Morgan, Citibank) for over eight years. Now, he is applying his skills to tackle one of the biggest health problems of our time: mental illness.
Founded at Entrepreneur First
Seed ($2.3 million) led by Kodori Ventures